Case 1: Faricimab in a high-need neovascular nAMD patient
Dr. Khanani shares the case of a neovascular nAMD patient with high disease activity who achieved significant vision improvement and fluid resolution after switching to faricimab.
Sponsored by Roche
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
